Switch to:
Also traded in: Germany, Switzerland, UK

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 9/10

vs
industry
vs
history
Cash to Debt No Debt
ISRG's Cash to Debt is ranked higher than
97% of the 323 Companies
in the Global Medical Devices industry.

( Industry Median: 2.59 vs. ISRG: No Debt )
Ranked among companies with meaningful Cash to Debt only.
ISRG' s Cash to Debt Range Over the Past 10 Years
Min: 12.85  Med: 10000.00 Max: No Debt
Current: No Debt
Equity to Asset 0.90
ISRG's Equity to Asset is ranked higher than
92% of the 301 Companies
in the Global Medical Devices industry.

( Industry Median: 0.65 vs. ISRG: 0.90 )
Ranked among companies with meaningful Equity to Asset only.
ISRG' s Equity to Asset Range Over the Past 10 Years
Min: 0.7  Med: 0.87 Max: 0.9
Current: 0.9
0.7
0.9
Interest Coverage No Debt
ISRG's Interest Coverage is ranked higher than
96% of the 198 Companies
in the Global Medical Devices industry.

( Industry Median: 53.44 vs. ISRG: No Debt )
Ranked among companies with meaningful Interest Coverage only.
ISRG' s Interest Coverage Range Over the Past 10 Years
Min: 9999.99  Med: 10000.00 Max: 9999.99
Current: No Debt
F-Score: 8
Z-Score: 27.89
M-Score: -2.48
WACC vs ROIC
3.31%
24.46%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 9/10

vs
industry
vs
history
Operating margin (%) 32.23
ISRG's Operating margin (%) is ranked higher than
97% of the 309 Companies
in the Global Medical Devices industry.

( Industry Median: 1.90 vs. ISRG: 32.23 )
Ranked among companies with meaningful Operating margin (%) only.
ISRG' s Operating margin (%) Range Over the Past 10 Years
Min: 25.56  Med: 35.70 Max: 40.3
Current: 32.23
25.56
40.3
Net-margin (%) 25.67
ISRG's Net-margin (%) is ranked higher than
95% of the 309 Companies
in the Global Medical Devices industry.

( Industry Median: 0.86 vs. ISRG: 25.67 )
Ranked among companies with meaningful Net-margin (%) only.
ISRG' s Net-margin (%) Range Over the Past 10 Years
Min: 19.33  Med: 24.38 Max: 30.14
Current: 25.67
19.33
30.14
ROE (%) 15.27
ISRG's ROE (%) is ranked higher than
82% of the 296 Companies
in the Global Medical Devices industry.

( Industry Median: 1.52 vs. ISRG: 15.27 )
Ranked among companies with meaningful ROE (%) only.
ISRG' s ROE (%) Range Over the Past 10 Years
Min: 12.17  Med: 18.96 Max: 21.36
Current: 15.27
12.17
21.36
ROA (%) 13.44
ISRG's ROA (%) is ranked higher than
91% of the 325 Companies
in the Global Medical Devices industry.

( Industry Median: -0.71 vs. ISRG: 13.44 )
Ranked among companies with meaningful ROA (%) only.
ISRG' s ROA (%) Range Over the Past 10 Years
Min: 10.59  Med: 16.51 Max: 18.44
Current: 13.44
10.59
18.44
ROC (Joel Greenblatt) (%) 138.42
ISRG's ROC (Joel Greenblatt) (%) is ranked higher than
98% of the 321 Companies
in the Global Medical Devices industry.

( Industry Median: 3.61 vs. ISRG: 138.42 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
ISRG' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: 114.4  Med: 186.03 Max: 245.9
Current: 138.42
114.4
245.9
Revenue Growth (3Y)(%) 5.90
ISRG's Revenue Growth (3Y)(%) is ranked higher than
59% of the 229 Companies
in the Global Medical Devices industry.

( Industry Median: 3.60 vs. ISRG: 5.90 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
ISRG' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: 0  Med: 20.10 Max: 57.1
Current: 5.9
0
57.1
EBITDA Growth (3Y)(%) -1.30
ISRG's EBITDA Growth (3Y)(%) is ranked lower than
53% of the 194 Companies
in the Global Medical Devices industry.

( Industry Median: 2.20 vs. ISRG: -1.30 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
ISRG' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -62.8  Med: 29.65 Max: 318.7
Current: -1.3
-62.8
318.7
EPS Growth (3Y)(%) -0.90
ISRG's EPS Growth (3Y)(%) is ranked lower than
54% of the 198 Companies
in the Global Medical Devices industry.

( Industry Median: 2.60 vs. ISRG: -0.90 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
ISRG' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -61.4  Med: 23.85 Max: 76.7
Current: -0.9
-61.4
76.7
» ISRG's 10-Y Financials

Financials (Next Earnings Date: Est. 2016-07-21)


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q2 2015

ISRG Guru Trades in Q2 2015

Ray Dalio 5,039 sh (New)
John Hussman 15,000 sh (+50.00%)
Robert Olstein 12,000 sh (+9.09%)
Manning & Napier Advisors, Inc 154,975 sh (+6.92%)
Vanguard Health Care Fund 414,400 sh (unchged)
John Burbank Sold Out
Joel Greenblatt Sold Out
RS Investment Management 35,505 sh (-7.31%)
Jeremy Grantham 133,965 sh (-14.08%)
Jim Simons 127,039 sh (-44.35%)
Steven Cohen 15,000 sh (-76.00%)
» More
Q3 2015

ISRG Guru Trades in Q3 2015

Joel Greenblatt 4,128 sh (New)
George Soros 1,100 sh (New)
Manning & Napier Advisors, Inc 595,225 sh (+284.08%)
Jim Simons 202,596 sh (+59.48%)
Ray Dalio 7,824 sh (+55.27%)
Vanguard Health Care Fund 440,200 sh (+6.23%)
Robert Olstein 12,500 sh (+4.17%)
John Hussman 15,000 sh (unchged)
RS Investment Management Sold Out
Jeremy Grantham 85,811 sh (-35.95%)
Steven Cohen 8,200 sh (-45.33%)
» More
Q4 2015

ISRG Guru Trades in Q4 2015

Paul Tudor Jones 1,800 sh (New)
Louis Moore Bacon 18,000 sh (New)
Steven Cohen 58,700 sh (+615.85%)
Vanguard Health Care Fund 519,996 sh (+18.13%)
Samuel Isaly 80,000 sh (unchged)
George Soros Sold Out
John Hussman Sold Out
Joel Greenblatt Sold Out
Manning & Napier Advisors, Inc 541,435 sh (-9.04%)
Jeremy Grantham 77,879 sh (-9.24%)
Robert Olstein 11,000 sh (-12.00%)
Jim Simons 109,170 sh (-46.11%)
Ray Dalio 2,024 sh (-74.13%)
» More
Q1 2016

ISRG Guru Trades in Q1 2016

Samuel Isaly 84,000 sh (+5.00%)
Manning & Napier Advisors, Inc 195,125 sh (-63.96%)
» More
» Details

Insider Trades

Latest Guru Trades with ISRG

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 38.00
ISRG's P/E(ttm) is ranked lower than
67% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 26.66 vs. ISRG: 38.00 )
Ranked among companies with meaningful P/E(ttm) only.
ISRG' s P/E(ttm) Range Over the Past 10 Years
Min: 17.79  Med: 38.41 Max: 107.27
Current: 38
17.79
107.27
Forward P/E 27.62
ISRG's Forward P/E is ranked lower than
84% of the 51 Companies
in the Global Medical Devices industry.

( Industry Median: 18.69 vs. ISRG: 27.62 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 38.00
ISRG's PE(NRI) is ranked lower than
66% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 26.94 vs. ISRG: 38.00 )
Ranked among companies with meaningful PE(NRI) only.
ISRG' s PE(NRI) Range Over the Past 10 Years
Min: 17.8  Med: 38.41 Max: 107.2
Current: 38
17.8
107.2
Price/Owner Earnings (ttm) 31.47
ISRG's Price/Owner Earnings (ttm) is ranked lower than
56% of the 109 Companies
in the Global Medical Devices industry.

( Industry Median: 30.78 vs. ISRG: 31.47 )
Ranked among companies with meaningful Price/Owner Earnings (ttm) only.
ISRG' s Price/Owner Earnings (ttm) Range Over the Past 10 Years
Min: 16.35  Med: 32.81 Max: 110.28
Current: 31.47
16.35
110.28
P/B 5.04
ISRG's P/B is ranked lower than
74% of the 295 Companies
in the Global Medical Devices industry.

( Industry Median: 2.93 vs. ISRG: 5.04 )
Ranked among companies with meaningful P/B only.
ISRG' s P/B Range Over the Past 10 Years
Min: 2.81  Med: 6.26 Max: 15.72
Current: 5.04
2.81
15.72
P/S 9.71
ISRG's P/S is ranked lower than
81% of the 291 Companies
in the Global Medical Devices industry.

( Industry Median: 3.18 vs. ISRG: 9.71 )
Ranked among companies with meaningful P/S only.
ISRG' s P/S Range Over the Past 10 Years
Min: 4.16  Med: 9.88 Max: 24.28
Current: 9.71
4.16
24.28
PFCF 30.37
ISRG's PFCF is ranked higher than
56% of the 96 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. ISRG: 30.37 )
Ranked among companies with meaningful PFCF only.
ISRG' s PFCF Range Over the Past 10 Years
Min: 18.41  Med: 33.83 Max: 128.48
Current: 30.37
18.41
128.48
POCF 27.79
ISRG's POCF is ranked lower than
67% of the 131 Companies
in the Global Medical Devices industry.

( Industry Median: 21.24 vs. ISRG: 27.79 )
Ranked among companies with meaningful POCF only.
ISRG' s POCF Range Over the Past 10 Years
Min: 11.34  Med: 28.02 Max: 84.53
Current: 27.79
11.34
84.53
EV-to-EBIT 27.97
ISRG's EV-to-EBIT is ranked lower than
61% of the 160 Companies
in the Global Medical Devices industry.

( Industry Median: 21.14 vs. ISRG: 27.97 )
Ranked among companies with meaningful EV-to-EBIT only.
ISRG' s EV-to-EBIT Range Over the Past 10 Years
Min: 10.2  Med: 27.00 Max: 74.4
Current: 27.97
10.2
74.4
EV-to-EBITDA 25.03
ISRG's EV-to-EBITDA is ranked lower than
67% of the 175 Companies
in the Global Medical Devices industry.

( Industry Median: 17.32 vs. ISRG: 25.03 )
Ranked among companies with meaningful EV-to-EBITDA only.
ISRG' s EV-to-EBITDA Range Over the Past 10 Years
Min: 9.5  Med: 24.40 Max: 63.8
Current: 25.03
9.5
63.8
PEG 8.06
ISRG's PEG is ranked lower than
73% of the 60 Companies
in the Global Medical Devices industry.

( Industry Median: 3.79 vs. ISRG: 8.06 )
Ranked among companies with meaningful PEG only.
ISRG' s PEG Range Over the Past 10 Years
Min: 0.15  Med: 0.95 Max: 16.15
Current: 8.06
0.15
16.15
Shiller P/E 59.56
ISRG's Shiller P/E is ranked lower than
62% of the 42 Companies
in the Global Medical Devices industry.

( Industry Median: 38.07 vs. ISRG: 59.56 )
Ranked among companies with meaningful Shiller P/E only.
ISRG' s Shiller P/E Range Over the Past 10 Years
Min: 43.97  Med: 84.00 Max: 244.46
Current: 59.56
43.97
244.46
Current Ratio 5.31
ISRG's Current Ratio is ranked higher than
77% of the 319 Companies
in the Global Medical Devices industry.

( Industry Median: 2.86 vs. ISRG: 5.31 )
Ranked among companies with meaningful Current Ratio only.
ISRG' s Current Ratio Range Over the Past 10 Years
Min: 2.07  Med: 4.63 Max: 7.43
Current: 5.31
2.07
7.43
Quick Ratio 4.95
ISRG's Quick Ratio is ranked higher than
80% of the 319 Companies
in the Global Medical Devices industry.

( Industry Median: 2.09 vs. ISRG: 4.95 )
Ranked among companies with meaningful Quick Ratio only.
ISRG' s Quick Ratio Range Over the Past 10 Years
Min: 1.72  Med: 4.30 Max: 7.07
Current: 4.95
1.72
7.07
Days Inventory 84.66
ISRG's Days Inventory is ranked higher than
73% of the 286 Companies
in the Global Medical Devices industry.

( Industry Median: 136.13 vs. ISRG: 84.66 )
Ranked among companies with meaningful Days Inventory only.
ISRG' s Days Inventory Range Over the Past 10 Years
Min: 55.48  Med: 71.72 Max: 91.85
Current: 84.66
55.48
91.85
Days Sales Outstanding 48.62
ISRG's Days Sales Outstanding is ranked higher than
77% of the 273 Companies
in the Global Medical Devices industry.

( Industry Median: 70.17 vs. ISRG: 48.62 )
Ranked among companies with meaningful Days Sales Outstanding only.
ISRG' s Days Sales Outstanding Range Over the Past 10 Years
Min: 48.57  Med: 62.89 Max: 92.73
Current: 48.62
48.57
92.73
Days Payable 26.39
ISRG's Days Payable is ranked lower than
83% of the 266 Companies
in the Global Medical Devices industry.

( Industry Median: 62.81 vs. ISRG: 26.39 )
Ranked among companies with meaningful Days Payable only.
ISRG' s Days Payable Range Over the Past 10 Years
Min: 23.81  Med: 32.95 Max: 58.29
Current: 26.39
23.81
58.29

Valuation & Return

vs
industry
vs
history
Price/Net Cash 19.06
ISRG's Price/Net Cash is ranked lower than
57% of the 107 Companies
in the Global Medical Devices industry.

( Industry Median: 15.00 vs. ISRG: 19.06 )
Ranked among companies with meaningful Price/Net Cash only.
ISRG' s Price/Net Cash Range Over the Past 10 Years
Min: 2.88  Med: 21.55 Max: 333.4
Current: 19.06
2.88
333.4
Price/Net Current Asset Value 12.90
ISRG's Price/Net Current Asset Value is ranked lower than
77% of the 215 Companies
in the Global Medical Devices industry.

( Industry Median: 6.20 vs. ISRG: 12.90 )
Ranked among companies with meaningful Price/Net Current Asset Value only.
ISRG' s Price/Net Current Asset Value Range Over the Past 10 Years
Min: 2.21  Med: 12.27 Max: 28.5
Current: 12.9
2.21
28.5
Price/Tangible Book 5.40
ISRG's Price/Tangible Book is ranked lower than
62% of the 266 Companies
in the Global Medical Devices industry.

( Industry Median: 3.89 vs. ISRG: 5.40 )
Ranked among companies with meaningful Price/Tangible Book only.
ISRG' s Price/Tangible Book Range Over the Past 10 Years
Min: 2.05  Med: 6.03 Max: 16.47
Current: 5.4
2.05
16.47
Price/Projected FCF 2.05
ISRG's Price/Projected FCF is ranked lower than
51% of the 118 Companies
in the Global Medical Devices industry.

( Industry Median: 2.08 vs. ISRG: 2.05 )
Ranked among companies with meaningful Price/Projected FCF only.
ISRG' s Price/Projected FCF Range Over the Past 10 Years
Min: 1.5  Med: 2.67 Max: 14.57
Current: 2.05
1.5
14.57
Price/DCF (Earnings Based) 1.34
ISRG's Price/DCF (Earnings Based) is ranked higher than
67% of the 18 Companies
in the Global Medical Devices industry.

( Industry Median: 1.87 vs. ISRG: 1.34 )
Ranked among companies with meaningful Price/DCF (Earnings Based) only.
N/A
Price/Median PS Value 0.99
ISRG's Price/Median PS Value is ranked higher than
55% of the 246 Companies
in the Global Medical Devices industry.

( Industry Median: 1.04 vs. ISRG: 0.99 )
Ranked among companies with meaningful Price/Median PS Value only.
ISRG' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.31  Med: 0.90 Max: 2.12
Current: 0.99
0.31
2.12
Price/Graham Number 3.02
ISRG's Price/Graham Number is ranked lower than
63% of the 178 Companies
in the Global Medical Devices industry.

( Industry Median: 2.14 vs. ISRG: 3.02 )
Ranked among companies with meaningful Price/Graham Number only.
ISRG' s Price/Graham Number Range Over the Past 10 Years
Min: 1.81  Med: 3.54 Max: 8
Current: 3.02
1.81
8
Earnings Yield (Greenblatt) (%) 3.61
ISRG's Earnings Yield (Greenblatt) (%) is ranked higher than
69% of the 310 Companies
in the Global Medical Devices industry.

( Industry Median: 0.50 vs. ISRG: 3.61 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
ISRG' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 1.3  Med: 3.70 Max: 9.8
Current: 3.61
1.3
9.8
Forward Rate of Return (Yacktman) (%) 5.06
ISRG's Forward Rate of Return (Yacktman) (%) is ranked lower than
53% of the 109 Companies
in the Global Medical Devices industry.

( Industry Median: 6.44 vs. ISRG: 5.06 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
ISRG' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: -1.1  Med: 30.00 Max: 141.9
Current: 5.06
-1.1
141.9

More Statistics

Revenue(Mil) $2447
EPS $ 16.47
Beta0.19
Short Percentage of Float5.03%
52-Week Range $447.00 - 654.88
Shares Outstanding(Mil)38.06

Analyst Estimate

Dec16 Dec17 Dec18
Revenue(Mil) 2,602 2,876 3,240
EPS($) 19.25 22.66 22.28
EPS without NRI($) 19.25 22.66 22.28

Business Description

Industry: Medical Devices » Medical Devices
Compare:NYSE:MDT, NYSE:ABT, NYSE:SYK, NYSE:BSX, NYSE:ZBH » details
Traded in other countries:IUI1.Germany, ISRG.Switzerland, 0R29.UK,
Intuitive Surgical Inc is a Delaware corporation founded in 1995. The Company designs, manufactures and markets da Vinci Surgical Systems and related instruments and accessories. A da Vinci Surgical System consists of a surgeon's console, a patient-side cart, and a high performance vision system. da Vinci Surgery utilizes computational, robotic and imaging technologies to enable improved patient outcomes compared to other surgical and non-surgical therapies. The Company has commercialized four generations of da Vinci Surgical System- the da Vinci Xi Surgical System, the da Vinci Si Surgical System, the da Vinci S Surgical System and the standard da Vinci Surgical System. da Vinci Surgical Systems are comprised of the following components: Surgeon's Console. The da Vinci Surgical System allows surgeons to operate while comfortably seated at an ergonomic console viewing a 3-D image of the surgical field. Patient-Side Cart. The patient-side cart holds electromechanical arms that manipulate the instruments inside the patient. 3-D Vision System. Its vision system includes its InSite 3-D endoscope with two separate vision channels linked to two separate color monitors through high performance video cameras and specialized image processing hardware. da Vinci Skills Simulator. The Skills Simulator is a practice tool that gives a user the opportunity to practice his or her facility with the surgeon console controls. EndoWrist instruments are offered in a variety of sizes, of which 5mm and 8mm diameter sizes are commonly sold. The Company provides its products through a direct sales organization in the U.S, mainly of Western Europe excluding Spain, Portugal, Italy and Greece; Japan and Korea. The Company's products and operations are subject to rigorous regulation by the FDA, the State of California and countries or regions in which the company markets its products.
» More Articles for NAS:ISRG

Headlines

Articles On GuruFocus.com
Weekly CFO Sells Highlights Mar 21 2016 
Nintai's Dual Circles of Comfort and Competence Mar 11 2016 
Best Performing Guru Stocks Mar 08 2016 
The 2016 Nintai Charitable Trust Portfolio: Annual Review Jan 18 2016 
Getting to Zero: Value and Risk Management Dec 04 2015 
Weekly Insider Sells Highlights: Nike, Intuitive Surgical, Travelers Companies, Stryker Oct 26 2015 
Guru Stocks at 52-Week Lows: Walmart, VMWare, Intuitive Surgical, Macy's, Nordstrom Oct 16 2015 
Weekly CFO Sells Highlight: GoPro Inc, Fortinet Inc, and Intuitive Surgical Inc. Aug 04 2015 
Weekly Insider Sells Highlight: ZION, PYPL, FTNT, ISRG Aug 02 2015 
Margin of Safety: How Much is Enough? Jun 08 2015 

More From Other Websites
ETF’s with exposure to Intuitive Surgical, Inc. : April 28, 2016 Apr 28 2016
Why Do Fund Managers Find This Top Medical Device Maker ‘Infectious’? Apr 28 2016
INTUITIVE SURGICAL INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission of... Apr 26 2016
INTUITIVE SURGICAL INC Financials Apr 26 2016
Intuitive Surgical, Inc. :ISRG-US: Earnings Analysis: Q4, 2015 By the Numbers Apr 26 2016
Medical Device Makers Keep Health Care Funds Off The Deathbed Apr 22 2016
Oil Soars; Intuitive Surgical & Manhattan Report Strong Earnings Apr 20 2016
GLOBAL MARKETS-Oil jumps 4 pct after stockpile data; dollar gains Apr 20 2016
Intuitive Surgical Q1 Impresses Wall Street, As Stock Hits New High Apr 20 2016
Early movers: KO, DISH, TUP, NLSN, GOOGL & more Apr 20 2016
Edited Transcript of ISRG earnings conference call or presentation 19-Apr-16 8:30pm GMT Apr 20 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK